Search Results - "KIM, Peter S"

Refine Results
  1. 1

    A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery by Tang, Shaogeng, Kim, Peter S.

    “…Immune checkpoint blockade of programmed death-1 (PD-1) by monoclonal antibody drugs has delivered breakthroughs in the treatment of cancer. Nonetheless,…”
    Get full text
    Journal Article
  2. 2

    Efficient evolution of human antibodies from general protein language models by Hie, Brian L., Shanker, Varun R., Xu, Duo, Bruun, Theodora U. J., Weidenbacher, Payton A., Tang, Shaogeng, Wu, Wesley, Pak, John E., Kim, Peter S.

    Published in Nature biotechnology (01-02-2024)
    “…Natural evolution must explore a vast landscape of possible sequences for desirable yet rare mutations, suggesting that learning from natural evolutionary…”
    Get full text
    Journal Article
  3. 3

    Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitope by Weidenbacher, Payton A., Kim, Peter S.

    “…In creating vaccines against infectious agents, there is often a desire to direct an immune response toward a particular conformational epitope on an antigen…”
    Get full text
    Journal Article
  4. 4

    Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model by Jenner, Adrianne L, Kelly, Wayne, Dallaston, Michael, Araujo, Robyn, Parfitt, Isobelle, Steinitz, Dominic, Pooladvand, Pantea, Kim, Peter S, Wade, Samantha J, Vine, Kara L

    Published in PLoS computational biology (01-01-2023)
    “…The prognosis for pancreatic ductal adenocarcinoma (PDAC) patients has not significantly improved in the past 3 decades, highlighting the need for more…”
    Get full text
    Journal Article
  5. 5

    Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies by Kim, Soohyun, Filsinger Interrante, Maria V, Kim, Peter S

    Published in Journal of virology (31-01-2023)
    “…Broadly neutralizing antibodies (bNAbs) against the membrane-proximal external region (MPER) of the gp41 component of the human immunodeficiency virus type 1…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The effects of inhibition and siRNA knockdown of collagen-binding integrins on human umbilical vein endothelial cell migration and tube formation by Hunter, Emma J., Hamaia, Samir W., Kim, Peter S.-K., Malcor, Jean-Daniel M., Farndale, Richard W.

    Published in Scientific reports (14-12-2022)
    “…Blood vessels in the body are lined with endothelial cells which have vital roles in numerous physiological and pathological processes. Collagens are major…”
    Get full text
    Journal Article
  8. 8

    A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV‑2 in Mice by Powell, Abigail E, Zhang, Kaiming, Sanyal, Mrinmoy, Tang, Shaogeng, Weidenbacher, Payton A, Li, Shanshan, Pham, Tho D, Pak, John E, Chiu, Wah, Kim, Peter S

    Published in ACS central science (27-01-2021)
    “…The development of a safe and effective SARS-CoV-2 vaccine is a public health priority. We designed subunit vaccine candidates using self-assembling ferritin…”
    Get full text
    Journal Article
  9. 9

    Increased longevity evolves from grandmothering by Kim, Peter S., Coxworth, James E., Hawkes, Kristen

    “…Postmenopausal longevity may have evolved in our lineage when ancestral grandmothers subsidized their daughters' fertility by provisioning grandchildren, but…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Legal medicine implications of a multidisciplinary approach to managing Traumatic Encephalopathy Syndrome in Australia by Kim, Peter S, Beran, Roy G

    Published in Frontiers in neurology (30-06-2023)
    “…The medical profession has a fundamental obligation to accurately diagnose and effectively treat a range of diseases and conditions. In the case of Traumatic…”
    Get full text
    Journal Article
  12. 12

    Human sperm TMEM95 binds eggs and facilitates membrane fusion by Tang, Shaogeng, Lu, Yonggang, Skinner, Will M., Sanyal, Mrinmoy, Lishko, Polina V., Ikawa, Masahito, Kim, Peter S.

    “…Tmem95 encodes a sperm acrosomal membrane protein, whose knockout has a male-specific sterility phenotype in mice. Tmem95 knockout murine sperm can bind to,…”
    Get full text
    Journal Article
  13. 13

    Grandmothering life histories and human pair bonding by Coxworth, James E., Kim, Peter S., McQueen, John S., Hawkes, Kristen

    “…The evolution of distinctively human life history and social organization is generally attributed to paternal provisioning based on pair bonds. Here we develop…”
    Get full text
    Journal Article
  14. 14

    Grandmothering drives the evolution of longevity in a probabilistic model by Kim, Peter S., McQueen, John S., Coxworth, James E., Hawkes, Kristen

    Published in Journal of theoretical biology (21-07-2014)
    “…We present a mathematical model based on the Grandmother Hypothesis to simulate how human post-menopausal longevity could have evolved as ancestral…”
    Get full text
    Journal Article
  15. 15

    Identification of HIV gp41-specific antibodies that mediate killing of infected cells by Williams, Katherine L, Stumpf, Megan, Naiman, Nicole Elise, Ding, Shilei, Garrett, Meghan, Gobillot, Theodore, Vézina, Dani, Dusenbury, Katharine, Ramadoss, Nitya S, Basom, Ryan, Kim, Peter S, Finzi, Andrés, Overbaugh, Julie

    Published in PLoS pathogens (01-02-2019)
    “…Antibodies that mediate killing of HIV-infected cells through antibody-dependent cellular cytotoxicity (ADCC) have been implicated in protection from HIV…”
    Get full text
    Journal Article
  16. 16

    Integrating Perspectives on Family Caregiving After Critical Illness: A Qualitative Content Analysis by Moale, Amanda C, Motter, Erica M, Eisenhauer, Peter, Gandhi, Nimit, Kim, S Peter, Girard, Tim D, Reynolds, 3rd, Charles F, Leland, Natalie E, Chang, Judy C, Scheunemann, Leslie P

    Published in American journal of critical care (01-05-2024)
    “…To date, no intervention has definitively improved outcomes for families of critical illness survivors. An integrated perspective on caregivers' needs after…”
    Get full text
    Journal Article
  17. 17

    Efficacy of a nucleoside-sparing regimen of darunavir/ ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262) by TAIWO, Babafemi, LU ZHENG, ERON, Joseph J, GALLIEN, Sebastien, MATINING, Roy M, KURITZKES, Daniel R, WILSON, Cara C, BERZINS, Baiba I, ACOSTA, Edward P, BASTOW, Barbara, KIM, Peter S

    Published in AIDS (London) (13-11-2011)
    “…To explore darunavir/ritonavir (DRV/r) plus raltegravir (RAL) combination therapy in antiretroviral-naive patients. Phase IIb, single-arm, open-label,…”
    Get full text
    Journal Article
  18. 18

    A1C Underestimates Glycemia in HIV Infection by Kim, Peter S, Woods, Christian, Georgoff, Patrick, Crum, Dana, Rosenberg, Alice, Smith, Margo, Hadigan, Colleen

    Published in Diabetes care (01-09-2009)
    “…OBJECTIVE: The objective of this study was to determine the relationship between A1C and glycemia in HIV infection. RESEARCH DESIGN AND METHODS: We completed a…”
    Get full text
    Journal Article
  19. 19

    Ensuring impact of long‐acting HIV therapeutics through multi‐level treatment research: a view from NIH by Kim, Peter S., Stirratt, Michael J., Morton, Tia M., Rausch, Dianne M.

    Published in Journal of the International AIDS Society (01-07-2023)
    “…Clinical strategies to enable treatment experienced PWH to benefit from LAEDs, including LAED treatment initiation without prior viral suppression using oral…”
    Get full text
    Journal Article
  20. 20

    Mature Dendritic Cells May Promote High-Avidity Tuning of Vaccine T Cell Responses by Kumbhari, Adarsh, Egelston, Colt A, Lee, Peter P, Kim, Peter S

    Published in Frontiers in immunology (30-10-2020)
    “…Therapeutic vaccines can elicit tumor-specific cytotoxic T lymphocytes (CTLs), but durable reductions in tumor burden require vaccines that stimulate…”
    Get full text
    Journal Article